Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;31:110-113

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andronico, G.
Right arrow Articles by Cerasola, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andronico, G.
Right arrow Articles by Cerasola, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*LITHIUM COMPOUNDS
*LITHIUM, ELEMENTAL
*SODIUM

(Hypertension. 1998;31:110.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Insulin, Sodium-Lithium Countertransport, and Microalbuminuria in Hypertensive Patients

Giuseppe Andronico; Lidia Ferrara; Mariateresa Mangano; Giuseppe Mulè; Giovanni Cerasola

From the Internal Medicine and Hypertension Centre, University of Palermo, Italy.

Abstract—Both microalbuminuria (>0.290 nmol/min [20 µg/min]) and high sodium-lithium countertransport (SLC) in diabetic or hypertensive humans are predictive of overt nephropathy and more aggressive cardiovascular complications, perhaps induced by insulin resistance. To analyze the relationships between microalbuminuria, SLC, microalbuminuria, and insulin in essential hypertension, we studied 90 hypertensive white patients, 25 of whom had microalbuminuria and 32 of whom were healthy. When urine sampling was completed for albuminuria determination, SLC was measured; all patients then underwent standard (75 g) oral glucose load to measure basal (0 minutes) and 2-hour glucose and insulin serum levels. Glucose-insulin ratio was used as insulin sensitivity index (ISI). In both hypertensive patients with normal microalbuminuria and those with pathological microalbuminuria, plasma insulin at 120 minutes was significantly higher than in control subjects. When the patients with pathological microalbuminuria were divided into thirds on the basis of their microalbuminuria, in the lower third, we found statistically significant less fasting insulin and higher basal ISI. SLC was higher in hypertensives than normotensives and, among hypertensives, higher in the subgroup with elevated microalbuminuria. In hypertensives, we found a weak but significant correlation between SLC and microalbuminuria, independent of insulin or ISI. The prevalence of high value of SLC (>=0.383 mmol · L-1 · h-1) was significantly lower in hypertensives with normal rather than abnormal urinary albumin excretion. Our results indicate that in nondiabetic hypertensive whites, higher microalbuminuria is accompanied by signs of insulin resistance; moreover, a link exists between SLC and microalbuminuria, both predictive of aggressive complications of hypertension.


Key Words: insulin • sodium-lithium countertransport • microalbuminuria • insulin resistance • cardiovascular risk • nephropathy




This article has been cited by other articles:


Home page
HypertensionHome page
S. Delbosc, J.-P. Cristol, B. Descomps, A. Mimran, and B. Jover
Simvastatin Prevents Angiotensin II-Induced Cardiac Alteration and Oxidative Stress
Hypertension, August 1, 2002; 40(2): 142 - 147.
[Abstract] [Full Text] [PDF]